Diligence memo · auto-generated · as of July 2, 2026
NanoPharmaceuticals LLC
NanoPharmaceuticals LLC looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
NanoPharmaceuticals LLC operates in Pharmaceuticals, based in Troy.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
NanoPharmaceuticals LLC has raised $6.6M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.6M on 2013-11-15.
Most recent recorded round closed around 2025-01-23.
Valuation (modeled)modeled
Provath models NanoPharmaceuticals LLC at approximately $2.2M (range $471K–$5.0M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.36× the median modeled value of Seed Pharmaceuticals companies in 2025–2027 (19 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 45 months.
Last raise 17 mo ago; this sector typically re-raises about every 13 months.
Slightly overdue versus sector cadence.
The last round was 2.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 47% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 4% of those peers.
Closest niche peers: Kairos Pharma, LTD., Branch Therapeutics, Inc., ResBiotic Nutrition, Inc., Califia Pharma, Inc., BTB Therapeutics, Inc..
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.